MDGL — MADRIGAL PHARMACEUTICALS INC
As of Q2 2026, 37 SEC-registered investment managers reported holding MDGL (MADRIGAL PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $4.12B across 7.86M shares. That is -22.1% by share count (-2.23M shares) versus the previous quarter, while reported value moved -19.3%. Ownership is concentrated: the five largest holders account for 58.1% of reported value and the top ten for 77.5%.
Compared with the prior quarter, 2 opened new positions, 13 added to existing stakes, 21 trimmed, 4 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
MDGL is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 1.81M | $1.05B | 0.01% | Hold |
| Janus Henderson Group history | Q1 2026 | 2.02M | $1.05B | 0.52% | Add |
| Paulson & Co history | Q2 2026 | 1.34M | $719.52M | 27.93% | Reduce |
| BlackRock Inc history | Q2 2026 | 1.20M | $644.75M | 0.01% | Reduce |
| Wellington Management Group history | Q2 2026 | 825.71K | $443.37M | 0.08% | Add |
| Citadel Advisors history | Q2 2026 | 688.13K | $369.49M | 0.04% | Add |
| UBS Group AG history | Q2 2026 | 401.71K | $215.70M | 0.03% | Add |
| Geode Capital Management history | Q2 2026 | 374.88K | $201.34M | 0.01% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 356.20K | $191.26M | 0.01% | Reduce |
| Invesco Ltd history | Q2 2026 | 301.44K | $161.86M | 0.01% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 246.28K | $132.24M | 0.01% | Reduce |
| Norges Bank Investment Management history | Q2 2026 | 213.89K | $114.85M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 184.32K | $98.97M | 0.01% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 162.27K | $87.13M | 0.04% | Add |
| Point72 Asset Management history | Q2 2026 | 142.63K | $76.58M | 0.09% | Reduce |
| Morgan Stanley history | Q2 2026 | 139.01K | $74.64M | 0.00% | Reduce |
| Bank of America Corp history | Q2 2026 | 134.04K | $71.97M | 0.01% | Reduce |
| BNY Mellon history | Q2 2026 | 128.52K | $69.01M | 0.01% | Reduce |
| Millennium Management history | Q2 2026 | 118.50K | $63.63M | 0.02% | Add |
| Marshall Wace history | Q2 2026 | 101.86K | $54.69M | 0.04% | Add |
New Positions (Q2 2026)
- Balyasny Asset Management 79.01K sh · $42.42M
- JPMorgan Chase & Co 29.47K sh · $16.01M
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 2.02M sh · $1.05B
- Bridgewater Associates sold 3.92K sh · $2.05M
- Farallon Capital Management sold 3.32K sh · $1.74M
- Principal Global Investors sold 1.24K sh · $648.58K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Paulson & Co | — | — | — | — | — | — | — | 350.20K | 500.00K | 1.11M | 1.77M | 1.85M | 2.04M | 2.04M | 2.10M | 2.09M | 1.91M | 1.71M | 1.39M | 1.34M |
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 1.46M | 1.49M | 1.49M | 1.44M | 1.56M | 1.64M | 1.56M | 1.20M |
| Wellington Management Group | 1.02M | 1.32M | 901.29K | 24.42K | 24.18K | 31.83K | 15.81K | — | — | 5.23K | — | — | 9.03K | 8.17K | 7.63K | 7.38K | 404.45K | 461.40K | 694.96K | 825.71K |
| Citadel Advisors | 130.69K | 153.60K | 140.15K | 144.09K | 168.54K | 591.59K | 277.84K | 253.31K | 378.93K | 126.09K | 217.31K | 140.49K | 186.25K | 175.67K | 106.40K | 310.54K | 171.97K | 184.13K | 602.54K | 688.13K |
| UBS Group AG | 21.61K | 22.13K | 29.73K | 18.18K | 25.46K | 96.69K | 30.92K | 23.23K | 56.19K | 88.38K | 125.42K | 173.24K | 180.63K | 325.27K | 321.51K | 505.71K | 217.34K | 102.64K | 117.78K | 401.71K |
| Geode Capital Management | 202.38K | 220.02K | 217.99K | 224.80K | 229.79K | 236.59K | 248.06K | 271.32K | 296.44K | 336.25K | 346.86K | 399.85K | 405.65K | 410.58K | 420.88K | 414.39K | 446.23K | 451.74K | 455.87K | 374.88K |
| Fidelity Management & Research (FMR) | 166.54K | 166.54K | 164.12K | 163.61K | 163.77K | 198.49K | 262.44K | 349.04K | 440.38K | 625.16K | 713.91K | 789.00K | 783.54K | 867.85K | 652.10K | 445.34K | 401.14K | 439.40K | 511.73K | 356.20K |
| Invesco Ltd | 7.65K | 7.08K | 5.27K | 5.33K | 5.97K | 32.98K | 22.09K | 22.72K | 7.11K | 8.66K | 80.19K | 133.76K | 120.25K | 129.07K | 132.93K | 200.36K | 299.56K | 365.31K | 329.52K | 301.44K |
| Goldman Sachs Group | 155.17K | 105.48K | 48.59K | 52.63K | 180.40K | 163.79K | 142.99K | 80.31K | 110.21K | 94.60K | 101.29K | 202.15K | 270.48K | 242.15K | 189.64K | 189.84K | 386.10K | 305.83K | 277.37K | 246.28K |
| Norges Bank Investment Management | — | — | — | — | — | 116.30K | — | — | — | 145.59K | — | 116.03K | — | 115.09K | — | 176.47K | — | 196.39K | — | 213.89K |
| Charles Schwab Investment Management | 82.87K | 86.72K | 88.47K | 88.25K | 89.48K | 91.45K | 91.62K | 98.42K | 109.50K | 120.21K | 122.69K | 138.31K | 147.97K | 150.75K | 151.25K | 153.09K | 213.65K | 219.10K | 216.72K | 184.32K |
| D. E. Shaw & Co | 48.22K | 32.49K | 22.77K | 22.18K | 22.98K | 153.44K | 28.74K | 9.40K | 30.41K | 50.12K | 67.96K | 46.75K | 53.80K | 101.94K | 129.91K | 143.68K | 174.78K | 193.65K | 127.34K | 162.27K |
| Point72 Asset Management | 30.10K | — | — | — | 22.88K | — | 3.99K | — | 172.90K | — | 243.57K | 40.96K | — | — | 65.86K | 110.88K | 41.23K | 136.74K | 234.91K | 142.63K |
| Morgan Stanley | 68.17K | 48.34K | 98.02K | 82.95K | 59.06K | 109.42K | 147.78K | 74.29K | 171.77K | 151.92K | 288.61K | 220.03K | 269.39K | 218.48K | 384.83K | 247.96K | 249.65K | 150.46K | 191.29K | 139.01K |
| Bank of America Corp | 4.74K | 38.40K | 44.38K | 10.37K | 40.36K | 92.80K | 53.32K | 104.30K | 109.50K | 134.90K | 113.31K | 239.55K | 214.89K | 217.83K | 245.96K | 277.22K | 244.29K | 416.02K | 189.53K | 134.04K |
| BNY Mellon | 44.70K | 34.74K | 36.13K | 36.49K | 40.70K | 42.97K | 43.76K | 56.50K | 58.79K | 62.18K | 57.88K | 73.81K | 60.36K | 60.21K | 60.79K | 88.94K | 97.78K | 136.87K | 135.91K | 128.52K |
| Millennium Management | 24.02K | 15.78K | — | 4.38K | 15.14K | 80.10K | 137.89K | 29.91K | 48.86K | 11.90K | 6.55K | 23.20K | 18.93K | 3.01K | 2.51K | 10.84K | 1.80K | 6.98K | 40.85K | 118.50K |
| Marshall Wace | — | 608 | — | — | — | — | 541.76K | 460.64K | 395.40K | 33.07K | — | 1.70K | 80.40K | 17.49K | 2.80K | 55.12K | 700 | 39.58K | 21.90K | 101.86K |
| Northern Trust Corp | 112.05K | 116.93K | 111.40K | 115.00K | 113.41K | 111.49K | 113.48K | 122.60K | 123.65K | 134.71K | 131.36K | 131.44K | 147.77K | 155.88K | 150.89K | 142.87K | 159.99K | 151.80K | 149.21K | 98.51K |
| Deutsche Bank AG | 20.84K | 35.40K | 49.68K | 49.37K | 51.45K | 61.87K | 59.18K | 37.03K | 43.87K | 59.40K | 46.55K | 46.57K | 48.94K | 43.66K | 25.94K | 24.11K | 37.34K | 192.11K | 98.07K | 83.92K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details